Press & Media

Media Resources &
Expert Commentary

MedClinic Partners principals are available for expert commentary on compounding pharmacy regulation, GLP-1 supply chains, medical practice M&A, and the peptide research market. Reach our press team directly.

Expert Commentary

Topics We Can Speak To

Our principals hold JD, MBA, PharmD, and MD credentials and have operated in the medical practice space for over 15 years. We're available for on-record interviews, background briefings, and expert commentary.

503A & 503B Compounding Compliance

FDA regulatory framework, state board requirements, and the compliance gap most providers don't know they have.

GLP-1 Supply Chain & Shortages

How compounding pharmacies fill the gap when brand-name GLP-1s are on shortage — and what providers need to know.

Medical Practice M&A Valuations

What PE groups are paying for med spas and weight loss clinics, and how patient count drives enterprise value.

Peptide Research Market

The regulatory landscape for RUO peptides, IRB enrollment, and what's driving demand among licensed providers.

Exit Tax Mitigation for Clinic Owners

Puerto Rico Act 60, installment sales, and other strategies that materially reduce the tax burden on a practice sale.

Patient Recapture & Retention

How clinics recover dormant GLP-1 patients and what compliance constraints govern outreach campaigns.

Company Boilerplate

About MedClinic Partners

MedClinic Partners (Research Sciences LLC) is a medical supply and advisory platform serving licensed medical providers across all 50 states. The company provides 503A and 503B compounded GLP-1s, USA-manufactured research peptides, and a full-service clinic advisory practice covering patient recapture, M&A transactions, and white-label supply infrastructure.

Founded by attorneys, pharmacists, and medical operators with over 15 years of plaintiff-side pharmaceutical litigation experience, MedClinic Partners was built to give licensed providers the supply infrastructure, patient retention tools, and advisory expertise they need to operate compliantly and grow profitably.

The company's M&A advisory practice holds JD and MBA credentials on every transaction and maintains direct relationships with the private equity groups and strategic acquirers actively acquiring medical practices. MedClinic Partners is headquartered in the United States and operates nationally.

Request Full Media Kit

Relevant Publications

Pharmacy TimesHealioMedCity NewsFierce HealthcareModern HealthcareBecker's Hospital ReviewDrug TopicsManaged Healthcare Executive

Key Facts

Legal nameResearch Sciences LLC dba MedClinic Partners
FoundedUnited States
CoverageAll 50 states — licensed supply network
CredentialsJD, MBA, PharmD, MD on staff
Specialties503A/503B, Peptides, M&A, Patient Recapture

Research & Resources

81+ Clinical & Regulatory Resources

Our blog covers 503A/503B compliance, GLP-1 clinical protocols, peptide research, M&A strategy, and practice management — written by our clinical and legal team.